Assessment of HIV-postexposure prophylaxis prescription quality after a training programme and assistance in decisions provided by a computer-based decision program: a cross-over study

Casalino, Enrique; Bouzid, Donia; Antoniol, Stephanie; Choquet, Christophe; Colosi, Luisa; Pereira, Laurent; Agbessi, Alexis; Kenway, Philippe; Yazdanpanah, Yazdan; Ghazali, Daniel Aiham

doi:10.1080/17843286.2021.1892422

Cited by 1 publication

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The risk behaviors that constituted PEP eligibility in acute care settings were predominantly consensual sex (with a partner with HIV or unknown HIV status) and sexual assault, while 1 study included patients exposed via soiled needles, assault injuries, bites, scratches, and saliva [ 22 ] and 1 study included sex workers (n = 2) [ 27 ]. One study did not report the risk behaviors [ 24 ].…”

Section: Pep Utilizationmentioning

confidence: 99%

Missed Opportunities: A Narrative Review on Why Nonoccupational Postexposure Prophylaxis for HIV Is Underutilized

Allan-Blitz,

Mayer

2024

Open Forum Infectious Diseases

View full text Add to dashboard Cite

Summary Post-exposure prophylaxis (PEP) is an important tool for preventing human immunodeficiency virus (HIV) infection, but remains underutilized. In this narrative review, we aim to summarize the frequency of missed opportunities for prescribing PEP among study from around the world, discuss the complexities of the challenges facing PEP provision, and describe possible solutions. We identified 20 studies published in the last 10 years among 43,832 individuals, of whom an estimated 41,477 were eligible for PEP. Of those eligible for PEP, PEP was prescribed among 27,705 (66.8%). There was a significant difference in PEP prescriptions between acute compared to non-acute care settings (63.5% vs 94.5%; p < 0.001). Emergent themes contributing to PEP underutilization included lack of provider and patient awareness, reduced PEP acceptability, HIV stigma and homophobia, lack of access (either to care or to medication), and stigmatizing policies. Each of these issues should be the focus of future PEP implementation efforts.

show abstract

Section: Pep Utilizationmentioning

confidence: 99%